Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuta Tomida

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Cancer Science|March 14, 2018
Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterationsHidejiro Torigoe, Kazuhiko Shien, Tatsuaki Takeda, et al.
Cancer Science|November 8, 2015
Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterationsKen Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi, et al.
Scientific Reports|October 4, 2023
Author Correction: Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism arrayYasuaki Tomioka, Seiichiro Sugimoto, Haruchika Yamamoto, et al.
Plos One|May 9, 2015
Extended RAS and BRAF Mutation Analysis Using Next-Generation SequencingKazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, et al.
Scientific Reports|August 9, 2017
PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastomaYoshihiro Otani, Joji Ishida, Kazuhiko Kurozumi, et al.
The Oncologist|November 18, 2017
Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659EHiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, et al.
International Journal of Oncology|October 18, 2016
MEK inhibitors against MET-amplified non-small cell lung cancerMasato Chiba, Yosuke Togashi, Shuta Tomida, et al.
International Journal of Oncology|April 4, 2019
Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesotheliomaHiroki Sato, Junichi Soh, Keisuke Aoe, et al.
Scientific Reports|January 14, 2017
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT featuresHiroki Sato, Kazuhiko Shien, Shuta Tomida, et al.
Molecular Cancer Therapeutics|May 22, 2016
Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCCYu Nakamura, Yosuke Togashi, Hirokazu Nakahara, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Cancer Science|March 14, 2018
Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterationsHidejiro Torigoe, Kazuhiko Shien, Tatsuaki Takeda, et al.
Cancer Science|November 8, 2015
Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterationsKen Suzawa, Shinichi Toyooka, Masakiyo Sakaguchi, et al.
Scientific Reports|October 4, 2023
Author Correction: Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism arrayYasuaki Tomioka, Seiichiro Sugimoto, Haruchika Yamamoto, et al.
Plos One|May 9, 2015
Extended RAS and BRAF Mutation Analysis Using Next-Generation SequencingKazuko Sakai, Junji Tsurutani, Takeharu Yamanaka, et al.
Scientific Reports|August 9, 2017
PIK3R1Met326Ile germline mutation correlates with cysteine-rich protein 61 expression and poor prognosis in glioblastomaYoshihiro Otani, Joji Ishida, Kazuhiko Kurozumi, et al.
The Oncologist|November 18, 2017
Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659EHiromasa Yamamoto, Shinichi Toyooka, Takashi Ninomiya, et al.
International Journal of Oncology|October 18, 2016
MEK inhibitors against MET-amplified non-small cell lung cancerMasato Chiba, Yosuke Togashi, Shuta Tomida, et al.
International Journal of Oncology|April 4, 2019
Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesotheliomaHiroki Sato, Junichi Soh, Keisuke Aoe, et al.
Scientific Reports|January 14, 2017
Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT featuresHiroki Sato, Kazuhiko Shien, Shuta Tomida, et al.
Molecular Cancer Therapeutics|May 22, 2016
Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCCYu Nakamura, Yosuke Togashi, Hirokazu Nakahara, et al.
Pageof 17